Article citationsMore>>

Khanna, D., Saggar, R., Mayes, M.D., Abtin, F., Clement, P.J., Maranian, P., et al. (2011) A One-Year, Phase I/IIa, Open-Label Pilot Trial of Imatinib Mesylate in the Treatment of Systemic Sclerosis-Associated Active Interstitial Lung Disease. Arthritis & Rheumatology, 63, 3540-3546. https://doi.org/10.1002/art.30548

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top